Compare POAS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POAS | DRIO |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.9M | 84.1M |
| IPO Year | 2025 | N/A |
| Metric | POAS | DRIO |
|---|---|---|
| Price | $1.18 | $11.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | ★ 1.5M | 18.0K |
| Earning Date | 02-25-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $128,328.00 | ★ $24,732,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.29 |
| 52 Week Low | $2.90 | $5.94 |
| 52 Week High | $7.40 | $17.74 |
| Indicator | POAS | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 70.50 | 49.56 |
| Support Level | $5.68 | $10.00 |
| Resistance Level | $6.93 | $11.25 |
| Average True Range (ATR) | 0.67 | 0.70 |
| MACD | 0.22 | 0.07 |
| Stochastic Oscillator | 81.50 | 65.14 |
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.